Janux Therapeutics, Inc.JANXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+22.8%
5Y CAGR+87.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+22.8%/yr
Annual compound
5Y CAGR
+87.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
23.1x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $41.27M | +0.5% |
| 2024 | $41.05M | +57.0% |
| 2023 | $26.14M | +17.4% |
| 2022 | $22.26M | +115.5% |
| 2021 | $10.33M | +477.4% |
| 2020 | $1.79M | +131.7% |
| 2019 | $772000.00 | - |